Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Sopheon Terug naar discussie overzicht

Sopheon september 2018

60 Posts
Pagina: 1 2 3 »» | Laatste | Omlaag ↓
  1. [verwijderd] 1 september 2018 10:41
    Wilde deze maand positief beginnen. Als de winst de rest van het jaar doorgroeit, zoals in het eerste half jaar dan zal de winst uitkomen voor 2018 op zo een 75 pence. Hang daar je K/W aan dan weet je wat jij van de koers mag verwachten. Voor mij zelf weet ik het:-))

    Fijn weekend

    trinko
  2. Gartje 1 september 2018 13:19
    Eerst maar eens door die bubbel van 10 pond heen, en dan hoop ik toch echt binnen een jaar op die 15 pond te komen, ben voorzichtig en blijf aan boord.
  3. forum rang 6 limomilo 4 september 2018 09:31
    Even wat voor moderater Henk. Wanneer worden de berichten over Sopheon eens bijgewerkt. Er zijn alleen maar berichten te lezen tot 2012. Is eigenlijk een heel slechte zaak, wanneer men ambieert een z.g. info baak voor de belegger te zijn.
  4. Gartje 5 september 2018 11:50
    Ik heb een beetje een gevoel dat we met de koers de verkeerde kant op gaan-:)) maar het jaar is nog lang dus heb er nog heel veel vertrouwen in!
  5. Gartje 5 september 2018 18:13
    Was vorig jaar precies hetzelfde pietje, er zijn altijd mensen die hopen een snelle rit te maken richting de cijfers, als dat dan uit blijft willen ze van hun stukjes af, mooie kansen om bij te kopen!
  6. Paiser 10 september 2018 08:03
    Doosan Bobcat North America Awards Sopheon Innovation Contract

    Innovation Market Warms Up to Software-as-a-Service

    Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, announces that it has received a contract from Doosan Bobcat North America to deploy its Accolade® software enterprise wide. This award represents additional evidence that the market is beginning to accept the software-as-a-service (SaaS) model for management of innovation processes and decision support.

    In spite of significant interest in the benefits of SaaS deployments, large organizations have been slow to move their innovation activities into the Cloud. A growing number of recent new client acquisitions by Sopheon, however, have opted for Sopheon’s SaaS solution. One such customer, Doosan Bobcat, whose software implementation went live just last month, selected Sopheon’s Accolade software as the solution of choice to manage the company’s portfolio of projects across a number of corporate groups. Doosan Bobcat purchased a software-as-a-service cloud solution over purchasing licenses in perpetuity and installing the software on premises.

    “We chose to partner with Sopheon on this initiative as they offered the best solution to help us maximize the performance of a range of critical business processes. Sopheon’s software will enable us to better align our people and investments with our strategic and financial goals.” said Twila Perhus, Director of Global IT PMO.

    For Further Information Contact:
    Barry Mence, Chairman
    Arif Karimjee, CFO Sopheon plc + 44 (0) 1276 919 560

    Carl Holmes / Giles Rolls (Corporate Finance)
    Alice Lane (ECM) finnCap Ltd + 44 (0) 20 7220 0500

    About Doosan Bobcat North America
    Doosan Bobcat North America is the U.S. and Canadian subsidiary of Doosan Bobcat Inc., representing the world-renowned brands of Bobcat® compact equipment, Doosan® portable power products and Geith® attachments. These companies are industry leaders in the engineering, manufacturing, and marketing of compact construction equipment, generators, air compressors, lighting systems, light compaction equipment, and attachments.

    About Sopheon
    Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.

    www.sopheon.com/doosan-bobcat-north-a...
  7. [verwijderd] 10 september 2018 09:05
    Contract evidences growing SaaS acceptance
    Accolade solution for Doosan Bobcat North America

    Sopheon has received a contract from Doosan Bobcat North America
    to deploy its Accolade software to manage Doosan Bobcat’s portfolio
    of projects across a number of corporate groups. The implementation
    went live in August.

    In its recent interim results announcement,
    Sopheon noted that it had signed a number of Software-as-a-Service
    (SaaS) deals and extensions including a major new win. Our estimates
    already reflect that backdrop. Doosan Bobcat’s decision to go with a
    SaaS contract is another example of the growing acceptance of the
    SaaS model within the market for enterprise innovation management
    solutions. In the results announcement, Sopheon also said that it
    planned to make specific investment in product, people and
    processes to further extend Accolade. This will provide impetus to the
    Group’s focus on expanding its “lifetime value” opportunities across
    a number of blue chip clients through extending the business
    application areas addressed by Accolade. It recently released
    Accolade version 12.1.
    Sopheon produced a strong performance in
    the first half of 2018 and the Group retains both good momentum and
    excellent revenue visibility. We look forward to further updates.
  8. Paiser 10 september 2018 12:56
    A growing number of recent new client acquisitions by Sopheon, however, have opted for Sopheon’s SaaS solution
  9. [verwijderd] 10 september 2018 13:56
    Praiser als het grote orders zijn waar ze iemand voor hebben aangetrokken, dan zou de inkomsten voor 2018 wel eens rond de 40 milj $ komen te liggen lijkt mij dat het er steeds zonniger uit begint te zien. Mijn bescheiden mening. En hoop dit jaar ook nog op een overname of merger.

    Gr trinko
  10. Lord Enki 13 september 2018 10:44
    We worden flink gepiepeld.

    Ik kan niet anders dan denken dat er een partij is die genoeg stukjes heeft om de kleine belegger uit te roken.

    Bangmakerij, want met de berichten van de afgelopen tijd, kun je een koersdaling gewoon niet rechtvaardigen.

    Ik blijf dus lekker zitten, koop bij en heb mijn horizon gelegd over vier jaar.

    Mits alles zo blijft natuurlijk.
    Geen advies dus, wel een hersenspinsel.
  11. Slimme Pietje 13 september 2018 11:02
    Dat begin ik nu ook te geloven! Waar blijven de institionele beleggers. Zou dit uitstekende happens te Klein zijn voor hun?
    Effie ik blij ook zitten!
  12. [verwijderd] 13 september 2018 23:27
    www.youinvest.co.uk/sharesmagazine/20...

    S ome readers will remember the name Sopheon (SPE:AIM) since we have updated many times on our previous Great Idea from 2 June 2017 at 330p. We actually first flagged the company in August 2016 at 202p. The shares have been on a rampant run, nudging above £10.00 twice this year. We still think there is very decent upside from current levels. Before we explain our reasons, it’s first important to understand what Sopheon does. The Surrey-based software company helps streamline the research and development process for clients and provides product lifecycle management tools. From early roots as a provider of process automation tools, it has emerged as an innovation management solution to complex manufacturers. Sopheon has more than 60,000 users across 50-plus countries worldwide, featuring the likes of NASA, Merck and BASF. Its Accolade platform is used on innovation projects worth an estimated £25bn. Analysts at stockbroker FinnCap calculate a fair value over the next year or so of roughly £13.00, and here’s why we agree.

    EXPANDING AND MORE PREDICTABLE Sopheon is successfully expanding beyond its traditional industrial engineering-type space. Areas like consumer goods, food and drink, and technology development are proving to be useful new growth areas, while the company is also closing watching insurance, automotive and other industries. Bit by bit Sopheon’s revenues are becoming more predictable. Half year to 30 June 2018 figures reveal recurring revenue grew to $13.7m from $10.5m a year earlier. Recurring revenue has roughly doubled in about three years. Once you factor in contracted maintenance income from multi-year licences, $27.2m of the current full year’s $31m forecast revenue is effectively in the bag, and that’s before the typically busy fourth quarter for new licence sales. FinnCap suggests current earnings expectations are pitched conservatively. That means there is ongoing potential for guidance upgrades, something the company has been able to do multiple times over the past few years. Forecast $0.432 earnings per share (EPS) this year will be less than the $0.472 achieved in 2017 but not something to worry about. It goes back to the conversion last December of loan notes into equity, a one-off event that will not impact the financial performance beyond 2018. FinnCap’s 2019 estimates call for EPS of $0.537 on unbroken revenue growth to $35m. The business had $15.5m net cash at the end of June this year (2017: $6.6m), forecast to rise to $21.4m by the end of 2019. It has also started paying dividends, although this year’s prospective yield is very small at 0.3%. (SF)
60 Posts
Pagina: 1 2 3 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.285
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.341
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.902
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.359
Aedifica 2 829
Aegon 3.257 320.054
AFC Ajax 537 7.018
Affimed NV 2 5.752
ageas 5.843 109.777
Agfa-Gevaert 13 1.856
Ahold 3.536 73.980
Air France - KLM 1.024 34.312
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.771
Alfen 12 16.320
Allfunds Group 3 1.191
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 335
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.484 114.757
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.820 240.257
AMG 965 125.719
AMS 3 73
Amsterdam Commodities 303 6.520
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.112
Apollo Alternative Assets 1 17
Apple 5 313
Arcadis 251 8.615
Arcelor Mittal 2.023 318.601
Archos 1 1
Arcona Property Fund 1 266
arGEN-X 15 9.106
Aroundtown SA 1 176
Arrowhead Research 5 9.270
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.677
ASML 1.762 76.917
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.650
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.665

Macro & Bedrijfsagenda

  1. 29 april

    1. NL producentenvertrouwen april
    2. Philips Q1-cijfers
    3. Fra BBP eerste kwartaal (voorlopig)
    4. AkzoNobel €1,54-ex-dividend
    5. Besi €2,15 ex-dividend
    6. Fugro €0,40 ex-dividend
    7. Heineken €1,04 ex-dividend
    8. Vastned €1,28 ex-dividend
    9. CTP €0,275 ex=dividend
    10. EU consumentenvertrouwen april (definitief)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht